Article
A three‐gene DNA methylation biomarker accurately classifies early stage prostate cancer
21 Aug 2019
Abstract excerpt
BACKGROUND: We identify and validate accurate diagnostic biomarkers for prostate cancer through a systematic evaluation of DNA methylation alterations. MATERIALS AND METHODS: We assembled three early prostate cancer cohorts (total patients = 699) from which we collected and processed over 1300 prostatectomy tissue samples for DNA extraction. Using real-time methylation-specific PCR, we measured normalized...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
